HHCP
IBB icon

Hilton Head Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History

Hilton Head Capital Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.47K Sell
34
-34
-50% -$5.84K ﹤0.01% 642
2026
Q1 		$11.5K Hold
68
– – 0.01% 572
2025
Q4 		$11.5K Buy
+68
New +$11K 0.01% 550

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Hilton Head Capital Partners's IBB Position: Q2 2026 in Review

Hilton Head Capital Partners reduced its iShares Biotechnology ETF (IBB) stake by 50% in Q2 2026, selling an estimated $5.84K and leaving 34 shares worth $6.47K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Hilton Head Capital Partners first reported a position in IBB in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.5K in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Hilton Head Capital Partners held 34 shares of iShares Biotechnology ETF worth $6.47K as of Q2 2026.
  • Hilton Head Capital Partners sold 34 iShares Biotechnology ETF shares in Q2 2026, an estimated $5.84K.
  • iShares Biotechnology ETF made up ﹤0.01% of Hilton Head Capital Partners's portfolio in Q2 2026, its #642 holding.
  • Hilton Head Capital Partners first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • Hilton Head Capital Partners's iShares Biotechnology ETF position peaked at $11.5K in Q1 2026.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Hilton Head Capital Partners's 13F filing for Q2 2026, filed 27 Jul 2026.